FDA Variance Request from Laina Callow - Comment Period Closed
Summary
The Food and Drug Administration (FDA) has closed the comment period for a variance request submitted by Laina Callow. The application, authored by CDRH, was available for public comment on regulations.gov.
What changed
The FDA has closed the public comment period for a variance request submitted by Laina Callow. The application, associated with docket ID FDA-2026-V-1611-0001 and authored by the Center for Devices and Radiological Health (CDRH), was made available for review and comment on the regulations.gov platform.
As the comment period is closed, regulated entities should no longer submit feedback on this specific variance request. Further actions or decisions by the FDA regarding this application will be communicated through official channels. Compliance officers should note that this pertains to a specific variance request and may not represent a broader policy change.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 2
Variance Application from Laina Callow
Restricted: Personally Identifiable Information
More Information
- Author(s) CDRH
Variance Application from Laina Callow - Redacted
More Information
- Author(s) CDRH
Download
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.